Immune checkpoint inhibitors
Immune checkpoint inhibitors “unmask” cancer cells so the immune system can identify and attack them.
Monoclonal antibodies
Monoclonal antibodies are specially designed immune system proteins that are injected into the body to seek out cancer cells and help destroy them.
Adoptive cell immunotherapy
Adoptive cell immunotherapy takes a patient’s own cells and treats them to better fight cancer in a lab setting. The cells are then reinfused into the patient’s body so they can find and attack cancer cells. In addition to killing cancer cells, this treatment may help protect you and result in long-term remission.
CAR T-cell therapy
Adoptive cell immunotherapy includes chimeric antigen receptor T-cell (CAR T-cell) therapy, which genetically reprograms your T-cells (a type of immune cell) to find and attack cancer cells throughout the body.
Henry Ford Health is one of the few cancer centers in Michigan that is certified to administer this advanced treatment. It is designed to treat the following blood cancers:
- B-cell acute lymphoblastic leukemia
- Diffuse large B-cell lymphoma
- Chronic lymphocytic leukemia
- Small lymphocytic lymphoma
- Mantle cell lymphoma
- Primary mediastinal lymphoma
- Follicular lymphoma
- Multiple myeloma
Vaccines
Vaccines are an injectable treatment developed using dead cancer cells. After being administered, they stimulate the immune system to target living cancer cells.
Non-specific immunotherapies
Non-specific immunotherapies do not target cancer cells directly but instead provide a boost to the immune system’s overall capabilities.